Publication | Closed Access

High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary artery disease: results from the Bezafibrate Infarction Prevention (BIP) study

Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseDiabetesBezafibrate Infarction PreventionDiabetes MellitusPreventive CardiologyPublic HealthMedicineGlucose LevelsAtherosclerosisEpidemiologyCoronary Artery Disease